ArticleCancer immunology, immunotherapy : CII2023

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model.

Jaya Lakshmi Thangaraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.